You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

H2 receptor antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

Active, not recruiting
  • Exercise
  • Histamine
  • Placebo: Placebo + exercise training.
  • +2 more
  • Ghent, Oost-Vlaanderen, Belgium
    Department of movement and sports sciences, Ghent University, Be
Nov 8, 2022

Drug Interaction Trial in Brisbane (Telaglenastat, Famotidine, Placebo for famotidine)

Completed
  • Drug Interaction
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic (formerly Q-Pharm)
Mar 8, 2021

H2 Receptor Antagonist and Proton Pump Inhibitor on Positivity

Not yet recruiting
  • COVID-19
  • No intervention (Retrospective Cohort Observational)
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 6, 2021

Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

Enrolling by invitation
  • Chronic Kidney Diseases
  • Aurora, Colorado
  • +5 more
Oct 18, 2022

Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

Recruiting
  • Adamantinomatous Craniopharyngioma
  • Recurrent Adamantinomatous Craniopharyngioma
  • Aurora, Colorado
  • +17 more
Jan 8, 2023

Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

Recruiting
  • Safety Issues
  • +2 more
  • Washington, District of Columbia
    Georgetown University
Dec 1, 2022

Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

Active, not recruiting
  • Breast Neoplasms
  • +7 more
  • Goodyear, Arizona
  • +38 more
Jun 29, 2022

Healthy Trial in Madison (Selpercatinib, Ranitidine, Omeprazole)

Completed
  • Healthy
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
Jan 12, 2023

Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

Not yet recruiting
  • Acute Respiratory Distress Syndrome
  • Placebo
  • Ondansetron Injection
  • Montréal, Quebec, Canada
    Hôpital Sacré-Coeur de Montréal
Aug 22, 2022

Burns Trial in Shanghai (Cetirizine, Midazolam and Fentanyl)

Recruiting
  • Burns
  • Shanghai, Shanghai, China
    Department of Burn, Ruijin Hospital, Shanghai Jiao Tong Universi
Nov 6, 2023

Type 2 Diabetes, Glucose Tolerance Impaired, Insulin Sensitivity Trial in San Antonio (REMD-477, Placebo Subcutaneous injection)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • San Antonio, Texas
    Texas Diabetes Institute
Dec 22, 2021

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

SMART Protocol vs Antagonist Protocol in IVF

Active, not recruiting
  • Diminished Ovarian Reserve
    • Montreal, Quebec, Canada
      Clinique Ovo
    Dec 22, 2022

    COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

    Recruiting
    • COVID-19
    • SARS-CoV2 Infection
    • Candesartan Cilexetil
    • +3 more
    • Guntur, India
    • +4 more
    Mar 13, 2022

    in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

    Withdrawn
    • in Vitro Fertilization
    • Poor Responder
    • Toronto, Ontario, Canada
      Mount Sinai Hospital
    Apr 7, 2022

    Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

    Active, not recruiting
    • Breast Neoplasms
    • Chuo Ku, Japan
    • +1 more
    Dec 19, 2022

    s to Learn More About Treatment With Steroidal Mineralocorticoid

    Active, not recruiting
    • Chronic Kidney Disease
    • +2 more
    • sMRA therapies
    • Whippany, New Jersey
      Many Locations
    Jan 30, 2023

    Diabetes Type 2 in Obese, Inflammation, Metabolic Disease Trial in Basel (Anakinra Prefilled Syringe)

    Recruiting
    • Diabetes Mellitus Type 2 in Obese
    • +3 more
    • Anakinra Prefilled Syringe
    • Basel, Basel BS, Switzerland
      University Hospital Basel
    Sep 7, 2021

    MDD, Treatment-Resistant Depression, Depression Trial run by the NIMH (Placebo, TS-161 (50 - 100 mg))

    Recruiting
    • Major Depressive Disorder
    • +2 more
    • Placebo
    • TS-161 (50 - 100 mg)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Spinal Cord Injuries, Myelopathy Trial in Cambridge (Istradefylline, low oxygen therapy)

    Not yet recruiting
    • Spinal Cord Injuries
    • Myelopathy
    • Cambridge, Massachusetts
      Spaulding Rehabilitation Hospital
    Jun 24, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +14 more
    • Biopsy
    • +25 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 12, 2022

    Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,

    Not yet recruiting
    • Neuroendocrine Neoplasia's (NENs)
    • Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
    • Basel, Switzerland
      Division of Nuclear Medicine, University Hospital Basel
    Apr 27, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +4 more
    • Adenosine A2B Receptor Antagonist PBF-1129
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 1, 2023

    In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)

    Not yet recruiting
    • In-stent Restenosis
    • Beijing, Beijing, China
      Fuwai Hospital
    Oct 15, 2023

    Pancreatitis, Acute Trial in Denmark, Sweden (Placebo treatment, Naldemedine 0.2 MG Oral Tablet)

    Recruiting
    • Pancreatitis, Acute
    • Placebo treatment
    • Naldemedine 0.2 MG Oral Tablet
    • Aalborg, Jutland, Denmark
    • +4 more
    Mar 7, 2022